COGT
Cogent Biosciences
$40.44
+$0.68 (+1.71%)Jul 27, 2026
Key metrics
The numbers that frame COGT today
- Market cap
- $6.91B
- P/E (TTM)
- -19.5
- EV / FCF
- -24.1
- ROIC
- -67%
- Div yield
- 0%
- Debt / equity
- 0.4
- 52wk Low
- $10.38
- 52wk High
- $43.73
Growth
Revenue and earnings trend for COGT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about COGT
Is Cogent Biosciences a good buy?
Hold. Cogent Biosciences has excellent momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case. We think Cogent Biosciences is selling at a high price.
What is the market capitalization of COGT?
Cogent Biosciences's market capitalization is $6.91B.
What is the P/E ratio for COGT stock?
Cogent Biosciences's current P/E ratio is -19.5.
What is the 52-week high for COGT stock?
The 52-week high for Cogent Biosciences is $43.73. The current close of $40.44 is 7.5% below that high.
What is the 52-week low for COGT stock?
The 52-week low for Cogent Biosciences is $10.38. The current close of $40.44 is 289.6% above that low.
Does COGT stock pay dividends?
Cogent Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for COGT?
Cogent Biosciences's Debt / Equity ratio is 0.39.